Ramsay Health Care (OTCMKTS:RMSYF – Get Free Report) and COMPASS Pathways (NASDAQ:CMPS – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, earnings, valuation and risk.
This is a summary of recent recommendations for Ramsay Health Care and COMPASS Pathways, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Ramsay Health Care||0||0||0||0||N/A|
COMPASS Pathways has a consensus price target of $45.00, suggesting a potential upside of 376.19%. Given COMPASS Pathways’ higher probable upside, analysts clearly believe COMPASS Pathways is more favorable than Ramsay Health Care.
Insider & Institutional Ownership
Valuation and Earnings
This table compares Ramsay Health Care and COMPASS Pathways’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Ramsay Health Care||N/A||N/A||N/A||$1.43||25.56|
|COMPASS Pathways||N/A||N/A||-$91.50 million||($2.35)||-4.02|
COMPASS Pathways is trading at a lower price-to-earnings ratio than Ramsay Health Care, indicating that it is currently the more affordable of the two stocks.
This table compares Ramsay Health Care and COMPASS Pathways’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Ramsay Health Care||N/A||N/A||N/A|
About Ramsay Health Care
Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.
About COMPASS Pathways
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Receive News & Ratings for Ramsay Health Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ramsay Health Care and related companies with MarketBeat.com's FREE daily email newsletter.